EBIT at other companies
Other financials
Where this comes from
Calculated from Agios Pharmaceuticals’s reported figures.
Plus components not separately reported this period.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's EBIT?
- Agios Pharmaceuticals (AGIO) reported EBIT of -$110.03M in Q1 2026.
- How has Agios Pharmaceuticals's EBIT changed year-over-year?
- Agios Pharmaceuticals's EBIT decreased by 3.2% year-over-year, from -$106.63M to -$110.03M.
- What is the long-term trend for Agios Pharmaceuticals's EBIT?
- Over 4 years (2021 to 2025), Agios Pharmaceuticals's EBIT has grown at a 5.7% compound annual growth rate (CAGR), from -$378.42M to -$472.13M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.